Cadila Pharma is a trusted partner in the U.S. pharmaceutical supply chain, committed to developing affordable medicines while upholding the highest ethical standards in clinical research. Through its U.S. subsidiary, Modavar Pharmaceuticals, the company has built long-standing collaborations across the United States, Canada, and other global markets, supplying high-quality APIs for many years.
Through our strategic business partnership program, Modavar Pharmaceuticals, the U.S. Subsidiary of Cadila Pharma, is a leading pharmaceutical company with a strong focus on providing US DMF APIs to the USA, Canada, and ROW markets.
Our long-established U.S. footprint, with dossier filings spanning multiple strengths and addressing diverse therapeutic needs.
This list of products and reference to any product therein should not be construed and/or constituted transaction where it is not permitted under Patent law of the country and/or is not authorized by other laws and regulations of the country.
A comprehensive range of APIs developed to meet U.S. DMF requirements and the quality expectations of regulated global markets.
This list of products and reference to any product therein should not be construed and/or constituted transaction where it is not permitted under Patent law of the country and/or is not authorized by other laws and regulations of the country.
Contact Us
Our Story
Businesses
Therapies
Corporate Identification No : U24231GJ1991PLC015132
©2026 Cadila Pharmaceuticals. All rights reserved
